EUPATI (European Patients Academy on Therapeutic Innovation)
IMI will fund this patient-led consortium to develop the 'European Patients' Academy on Therapeutic Innovation' (EUPATI). From 2012, the academy will educate patient representatives and the lay public on personalised and predictive medicine, design and conduct of clinical trials, drug safety and risk/benefit assessment, pharmaco-economics as well as patient involvement in drug development.
EUPATI will provide educational material in six European languages targeting eleven European countries.
contact datails
An introductory video can be found on http://www.youtube.com/user/eu2p.
EMTRAIN
EMTRAIN (European Medicines Research Training Network)
EUPATI
EUPATI (European Patients Academy on Therapeutic Innovation)
IMI will fund this patient-led consortium to develop the 'European Patients' Academy on Therapeutic Innovation' (EUPATI). From 2012, the academy will educate patient representatives and the lay public on personalised and predictive medicine, design and conduct of clinical trials, drug safety and risk/benefit assessment, pharmaco-economics as well as patient involvement in drug development.
EUPATI will provide educational material in six European languages targeting eleven European countries.
Eu2P
An introductory video can be found on http://www.youtube.com/user/eu2p.
PharmaTrain
PharmaTrain Courses
|
|
SafeSciMET
SafeSciMET (European Modular Education and Training Programme in Safety Sciences for Medicines) develops and delivers a pan-European education and training programme on drug safety emphasizing integrative and translational aspects lacking largely in today's educational programmes. The programme aims at delivering a new breed of drug safety scientists embracing new technologies to enhance innovative approaches to drug discovery and development. First courses have started in 2010.
About SafeSciMET
|
|
PharmaTrain Courses
|
|
EXECUTIVE MASTERS IN MANAGEMENT OF RESEARCH INFRASTRUCTURES
Develop your skills for leading Research Infrastructures with global impact
RItrain and University of Milano-Bicocca launch a unique international management development programme
Call for application
Course on Translational Research and Medicine Development: The C-COMEND Course is a course consisting of an introductory e-learning (~24 hours student investment time) followed by a 5-day face-to-face workshop. The course is intended for PhD students in the second half of their PhD and early postdocs who are involved in translational research. The course will empower participants to make a difference in translational medicine through inspiration and awareness.
Dates
E-learning course July – September 2017 (total 24 hours)
Face-to-face course 9th- 13th October 2017
Location
The course will be hosted in Berlin, by the Berlin-Brandenburg Center for Regenerative Therapy (BCRT), an alliance between the Charité and the Helmholtz Association.
Registration (now open)
Apply today to participate (deadline June 1st, 2017): https://www.helmholtz-hzi.de/de/aktuelles/veranstaltungen/c_comend/overview/
EMTRAIN - official project end September 30
The EMTRAIN project has ended on September 30 2016.
We would like to thank you all for the great collaboration during the past seven years.
EMBL agreed to support a second Lifelong learning workshop 2017
Save the date for the second Lifelong learning Workshop 05.-07. December 2017. More information will follow!
Publication of all EMBL Lifelong Learning Conference contributions out now
30.08.2016 - Speaker and poster abstracts published in the journal Intrinsic Activity
Read more ...